The results showed that LY294002 could significantly inhibit the growth of SACC-LM cells induced by CCL25, but the number of dead tumor cells did not increase significantly when CCR9 inhibitor (VCN) was added into the tumor cells with the present of LY294002. This evidence concerns the gene CCL25 and neoplasm.